Recombinant proteins of spike protein of SARS-CoV-2 with the Omicron receptor-binding domain induce production of highly Omicron-specific neutralizing antibodies.

Kang, Hyangju; Kim, Daniel; Min, Kyungmin; Park, Minhee; Kim, Seok-Hyun; Sohn, Eun-Ju; Choi, Bo-Hwa; Hwang, Inhwan

Kang, Hyangju; Kim, Daniel; Min, Kyungmin; Park, Minhee; Kim, Seok-Hyun; Sohn, Eun-Ju; Choi, Bo-Hwa; Hwang, Inhwan.

Afiliação

Kang H; BioApplications Inc., Pohang Technopark Complex, Pohang, Korea.
Kim D; BioApplications Inc., Pohang Technopark Complex, Pohang, Korea.
Min K; BioApplications Inc., Pohang Technopark Complex, Pohang, Korea.
Park M; BioApplications Inc., Pohang Technopark Complex, Pohang, Korea.
Kim SH; R&D Center, EyeGene, Goyang, Korea.
Sohn EJ; BioApplications Inc., Pohang Technopark Complex, Pohang, Korea.
Choi BH; BioApplications Inc., Pohang Technopark Complex, Pohang, Korea.
Hwang I; Department of Life Sciences, Pohang University of Science and Technology, Pohang, Korea.

Clin Exp Vaccine Res ; 11(3): 285-289, 2022 Sep.

Article em En | MEDLINE | ID: mdl-36451664